Factor structure and psychometric properties of the Greek version of the Reconstructed Depressive Experiences Questionnaire

Abstract

Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attention for new clinical applications. Through electromagnetic induction cortical activity can be modulated and therapeutic effects can be achieved in a variety of psychiatric and neurological conditions. According to the World Health Organization (WHO) depression is the most disabling disease in the world and 350 million people suffer from depression globally. Major depression is the most common disorder to be treated with TMS and the first mental disorder for which TMS received approval from the US Food and Drug Administration (FDA). We here introduce the basic principles of TMS, discuss the latest data on safety and side effects, and present various TMS treatment protocols as well as treatment response predictors in major depressive disorder.

Factors associated with anxiety and depression in cancer patients: Demographic factors and the role of demoralization and satisfaction with care

“…Demoralization was measured using the Greek version of Demoralization SCALE II, DS II, originally created by Robinson et al. (2016), 20,21 consisted of 16 questions encompassing aspects of demoralization such as helplessness, disheartenment, loss of meaning. Higher scores are indicative of higher levels of existential distress.…”

“…Higher scores are indicative of higher levels of existential distress. The Greek DS‐II presents excellent internal consistency (DS Factor I a = 0.906, DS Factor II a = 0.810, DS II total a = 0.913) and high test‐retest reliability (correlation coefficient >0.89) 21 …”